Julianne M Kalbaugh
Overview
Explore the profile of Julianne M Kalbaugh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
56
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalbaugh C, Kalbaugh J, McManus L, Fisher J
PLoS One
. 2021 Sep;
16(9):e0256994.
PMID: 34492044
Background: Increasing the diversity of research participants is an important focus of clinical trials. However, little is known regarding who enrolls as healthy volunteers in Phase I clinical trials, which...
2.
Fisher J, McManus L, Kalbaugh J, Walker R
Clin Trials
. 2021 May;
18(4):477-487.
PMID: 33938244
Background/aims: Financial compensation for research participation is a major focus of ethical concern regarding human subject recruitment. Phase I trials are sometimes considered to be a lucrative source of income...
3.
Fisher J, McManus L, Cottingham M, Kalbaugh J, Wood M, Monahan T, et al.
PLoS Med
. 2018 Nov;
15(11):e1002698.
PMID: 30457992
Background: There is limited research on healthy volunteers' perceptions of the risks of Phase I clinical trials. In order to contribute empirically to long-standing ethical concerns about healthy volunteers' involvement...
4.
Fisher J, McManus L, Wood M, Cottingham M, Kalbaugh J, Monahan T, et al.
J Empir Res Hum Res Ethics
. 2018 Oct;
13(5):494-510.
PMID: 30296882
Other than the financial motivations for enrolling in Phase I trials, research on how healthy volunteers perceive the benefits of their trial participation is scant. Using qualitative interviews conducted with...
5.
Cottingham M, Kalbaugh J, Swezey T, Fisher J
J Acquir Immune Defic Syndr
. 2018 Sep;
79 Suppl 1:S30-S36.
PMID: 30222703
As with all early-stage testing of investigational drugs, clinical trials targeting HIV/AIDS can pose unknown risks to research subjects. Unlike sick participants seeking a therapeutic benefit, the motivations and barriers...